Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2046-4053
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature ; volume:9 ; number:1 ; day:13 ; month:8 ; year:2020 ; pages:1-9 ; date:12.2020
Systematic Reviews ; 9, Heft 1 (13.8.2020), 1-9, 12.2020
- Creator
-
Sartori, Daniele
Aronson, Jeffrey K.
Onakpoya, Igho J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13643-020-01429-z
- URN
-
urn:nbn:de:101:1-2020100700324876988338
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-08-14T10:50:11+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sartori, Daniele
- Aronson, Jeffrey K.
- Onakpoya, Igho J.
- SpringerLink (Online service)
Other Objects (12)
Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature
Governance and pharmacovigilance in Brazil: a scoping review
Understanding a communicated thought
Involving stakeholders in research priority setting: a scoping review
Correction to: Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review
Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature
Governance and pharmacovigilance in Brazil: a scoping review
Understanding a communicated thought
Involving stakeholders in research priority setting: a scoping review
Correction to: Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review
Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature
Governance and pharmacovigilance in Brazil: a scoping review
Understanding a communicated thought
Involving stakeholders in research priority setting: a scoping review
Correction to: Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review
Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database